Daniyal Hussain
Executive Director, Technology Business Development - GSK
Daniyal is the Executive Director of the Technology Business Development organization at GSK. He focuses on novel platforms, data generation technologies and artificial intelligence in relation to drug discovery and development. Previously he was at Valo Health and has established data partnerships, in-licensed assets, acquired platforms and formed strategic partnerships. Prior to Valo he was in AstraZeneca's Immuno-Oncology strategy group.
Sessions
-
Wednesday - May 29, 2024 - 10:00
AI Partnerships with Pharma – What Pharma partners look for and key deal considerations
-
Wednesday - May 29, 2024 - 17:00
Panel Discussion: Advancing Drug Discovery and Patient Care: The Synergy of Emerging Technologies in Pharma-Health Collaboration
- Why is it important for pharma and healthcare to work together? •
- The changing patient behaviour in the digital era
- Why is it essential to be prompt in identifying and addressing the patient’s needs?
- How will digitization help bring patients on board?
- Progress made by companies so far
- Strategies to be adopted to increase patient –company data flow
Stay Informed
Subscribe today to receive news on latest updates,
offers and upcoming conferences via email
follow us
Follow us online to stay up to date about our conferences
For general conference and registration enquires please contact the below email id or fill out the form
info@corvusglobalevents.com
+44 (0) 207 096
0786
Experience the power of community building
Comprehensive Event Listings
Swift Event Registration
Enhanced Networking Opportunities
In-App Chat Feature
Schedule Meetings
Interactive session participation
Real-time event updates and notifications
Feedback and survey tools
Badge Scanning
Robust security and data protection
Continuous Connectivity for long-term professional relationships
